Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 45 of 45 entries
Sorted by: Best Match Show Resources per page
A Biomechanical Comparison of the Arciero and LaPrade Reconstruction for Posterolateral Corner Knee Injuries.

Orthopaedic journal of sports medicine

Treme GP, Salas C, Ortiz G, Gill GK, Johnson PJ, Menzer H, Richter DL, Qeadan F, Wascher DC, Schenck RC.
PMID: 31019985
Orthop J Sports Med. 2019 Apr 15;7(4):2325967119838251. doi: 10.1177/2325967119838251. eCollection 2019 Apr.

BACKGROUND: Injury to the posterolateral corner (PLC) of the knee requires reconstruction to restore coronal and rotary stability. Two commonly used procedures are the Arciero reconstruction technique (ART) and the LaPrade reconstruction technique (LRT). To the authors' knowledge, these...

Cite
Treme GP, Salas C, Ortiz G, et al. A Biomechanical Comparison of the Arciero and LaPrade Reconstruction for Posterolateral Corner Knee Injuries. Orthop J Sports Med. 2019;7(4):2325967119838251doi: 10.1177/2325967119838251.
Treme, G. P., Salas, C., Ortiz, G., Gill, G. K., Johnson, P. J., Menzer, H., Richter, D. L., Qeadan, F., Wascher, D. C., & Schenck, R. C. (2019). A Biomechanical Comparison of the Arciero and LaPrade Reconstruction for Posterolateral Corner Knee Injuries. Orthopaedic journal of sports medicine, 7(4), 2325967119838251. https://doi.org/10.1177/2325967119838251
Treme, Gehron P, et al. "A Biomechanical Comparison of the Arciero and LaPrade Reconstruction for Posterolateral Corner Knee Injuries." Orthopaedic journal of sports medicine vol. 7,4 (2019): 2325967119838251. doi: https://doi.org/10.1177/2325967119838251
Treme GP, Salas C, Ortiz G, Gill GK, Johnson PJ, Menzer H, Richter DL, Qeadan F, Wascher DC, Schenck RC. A Biomechanical Comparison of the Arciero and LaPrade Reconstruction for Posterolateral Corner Knee Injuries. Orthop J Sports Med. 2019 Apr 15;7(4):2325967119838251. doi: 10.1177/2325967119838251. eCollection 2019 Apr. PMID: 31019985; PMCID: PMC6466468.
Copy Download .nbib Format: NLM
Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration Database.

JAMA oncology

Anscher MS, Arora S, Weinstock C, Amatya A, Bandaru P, Tang C, Girvin AT, Fiero MH, Tang S, Lubitz R, Amiri-Kordestani L, Theoret MR, Pazdur R, Beaver JA.
PMID: 34989781
JAMA Oncol. 2022 Jan 06; doi: 10.1001/jamaoncol.2021.6439. Epub 2022 Jan 06.

IMPORTANCE: Immune checkpoint inhibitors (ICIs) and radiation therapy (RT) are widely used to treat various cancers, but little data are available to guide clinicians on ICI use sequentially with RT.OBJECTIVE: To assess whether there is an increased risk of...

Cite
Anscher MS, Arora S, Weinstock C, et al. Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration Database. JAMA Oncol. 2022;doi: 10.1001/jamaoncol.2021.6439.
Anscher, M. S., Arora, S., Weinstock, C., Amatya, A., Bandaru, P., Tang, C., Girvin, A. T., Fiero, M. H., Tang, S., Lubitz, R., Amiri-Kordestani, L., Theoret, M. R., Pazdur, R., & Beaver, J. A. (2022). Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration Database. JAMA oncology, . https://doi.org/10.1001/jamaoncol.2021.6439
Anscher, Mitchell S, et al. "Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration Database." JAMA oncology vol. (2022). doi: https://doi.org/10.1001/jamaoncol.2021.6439
Anscher MS, Arora S, Weinstock C, Amatya A, Bandaru P, Tang C, Girvin AT, Fiero MH, Tang S, Lubitz R, Amiri-Kordestani L, Theoret MR, Pazdur R, Beaver JA. Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration Database. JAMA Oncol. 2022 Jan 06; doi: 10.1001/jamaoncol.2021.6439. Epub 2022 Jan 06. PMID: 34989781.
Copy Download .nbib Format: NLM
Biomarkers of Cerebral Injury for Prediction of Postoperative Cognitive Dysfunction in Patients Undergoing Cardiac Surgery.

Journal of cardiothoracic and vascular anesthesia

Wiberg S, Holmgaard F, Zetterberg H, Nilsson JC, Kjaergaard J, Wanscher M, Langkilde AR, Hassager C, Rasmussen LS, Blennow K, Vedel AG.
PMID: 34130895
J Cardiothorac Vasc Anesth. 2022 Jan;36(1):125-132. doi: 10.1053/j.jvca.2021.05.016. Epub 2021 May 16.

OBJECTIVES: To assess the ability of the biomarkers neuron-specific enolase (NSE), tau, neurofilament light chain (NFL), and glial fibrillary acidic protein (GFAP) to predict postoperative cognitive dysfunction (POCD) at discharge in patients who underwent cardiac surgery.DESIGN: Post hoc analyses...

Cite
Wiberg S, Holmgaard F, Zetterberg H, et al. Biomarkers of Cerebral Injury for Prediction of Postoperative Cognitive Dysfunction in Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2021;36(1):125-132doi: 10.1053/j.jvca.2021.05.016.
Wiberg, S., Holmgaard, F., Zetterberg, H., Nilsson, J. C., Kjaergaard, J., Wanscher, M., Langkilde, A. R., Hassager, C., Rasmussen, L. S., Blennow, K., & Vedel, A. G. (2022). Biomarkers of Cerebral Injury for Prediction of Postoperative Cognitive Dysfunction in Patients Undergoing Cardiac Surgery. Journal of cardiothoracic and vascular anesthesia, 36(1), 125-132. https://doi.org/10.1053/j.jvca.2021.05.016
Wiberg, Sebastian, et al. "Biomarkers of Cerebral Injury for Prediction of Postoperative Cognitive Dysfunction in Patients Undergoing Cardiac Surgery." Journal of cardiothoracic and vascular anesthesia vol. 36,1 (2022): 125-132. doi: https://doi.org/10.1053/j.jvca.2021.05.016
Wiberg S, Holmgaard F, Zetterberg H, Nilsson JC, Kjaergaard J, Wanscher M, Langkilde AR, Hassager C, Rasmussen LS, Blennow K, Vedel AG. Biomarkers of Cerebral Injury for Prediction of Postoperative Cognitive Dysfunction in Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2022 Jan;36(1):125-132. doi: 10.1053/j.jvca.2021.05.016. Epub 2021 May 16. PMID: 34130895.
Copy Download .nbib Format: NLM
Is Diagnostic Arthroscopy at the Time of Medial Patellofemoral Ligament Reconstruction Necessary?.

Orthopaedic journal of sports medicine

Shultz CL, Schrader SN, Packard BD, Wascher DC, Treme GP, Richter DL.
PMID: 32944586
Orthop J Sports Med. 2020 Aug 31;8(8):2325967120945654. doi: 10.1177/2325967120945654. eCollection 2020 Aug.

BACKGROUND: Although medial patellofemoral ligament (MPFL) reconstruction is well described for patellar instability, the utility of arthroscopy at the time of stabilization has not been fully defined.PURPOSE: To determine whether diagnostic arthroscopy in conjunction with MPFL reconstruction is associated...

Cite
Shultz CL, Schrader SN, Packard BD, et al. Is Diagnostic Arthroscopy at the Time of Medial Patellofemoral Ligament Reconstruction Necessary?. Orthop J Sports Med. 2020;8(8):2325967120945654doi: 10.1177/2325967120945654.
Shultz, C. L., Schrader, S. N., Packard, B. D., Wascher, D. C., Treme, G. P., & Richter, D. L. (2020). Is Diagnostic Arthroscopy at the Time of Medial Patellofemoral Ligament Reconstruction Necessary?. Orthopaedic journal of sports medicine, 8(8), 2325967120945654. https://doi.org/10.1177/2325967120945654
Shultz, Christopher L, et al. "Is Diagnostic Arthroscopy at the Time of Medial Patellofemoral Ligament Reconstruction Necessary?." Orthopaedic journal of sports medicine vol. 8,8 (2020): 2325967120945654. doi: https://doi.org/10.1177/2325967120945654
Shultz CL, Schrader SN, Packard BD, Wascher DC, Treme GP, Richter DL. Is Diagnostic Arthroscopy at the Time of Medial Patellofemoral Ligament Reconstruction Necessary?. Orthop J Sports Med. 2020 Aug 31;8(8):2325967120945654. doi: 10.1177/2325967120945654. eCollection 2020 Aug. PMID: 32944586; PMCID: PMC7466890.
Copy Download .nbib Format: NLM
Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines?.

European heart journal. Acute cardiovascular care

Bro-Jeppesen J, Kjaergaard J, Wanscher M, Pedersen F, Holmvang L, Lippert FK, Møller JE, Køber L, Hassager C.
PMID: 24062920
Eur Heart J Acute Cardiovasc Care. 2012 Dec;1(4):291-301. doi: 10.1177/2048872612465588.

AIMS: To describe the use of emergency coronary angiography (CAG) and primary percutaneous coronary intervention (PCI) and the association with short- and long-term survival in consecutive comatose survivors after out-of-hospital cardiac arrest (OHCA).METHODS: In the period 2004-10, a total...

Cite
Bro-Jeppesen J, Kjaergaard J, Wanscher M, et al. Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines?. Eur Heart J Acute Cardiovasc Care. 2012;1(4):291-301doi: 10.1177/2048872612465588.
Bro-Jeppesen, J., Kjaergaard, J., Wanscher, M., Pedersen, F., Holmvang, L., Lippert, F. K., Møller, J. E., Køber, L., & Hassager, C. (2012). Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines?. European heart journal. Acute cardiovascular care, 1(4), 291-301. https://doi.org/10.1177/2048872612465588
Bro-Jeppesen, John, et al. "Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines?." European heart journal. Acute cardiovascular care vol. 1,4 (2012): 291-301. doi: https://doi.org/10.1177/2048872612465588
Bro-Jeppesen J, Kjaergaard J, Wanscher M, Pedersen F, Holmvang L, Lippert FK, Møller JE, Køber L, Hassager C. Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines?. Eur Heart J Acute Cardiovasc Care. 2012 Dec;1(4):291-301. doi: 10.1177/2048872612465588. PMID: 24062920; PMCID: PMC3760568.
Copy Download .nbib Format: NLM
CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle.

Diabetes research and clinical practice

Schernthaner G, Wanner C, Jurišić-Eržen D, Guja C, Gumprecht J, Jarek-Martynowa IR, Karasik A, Lalić N, Mankovsky BN, Prázný M, Tankova T, Tsur A, Wascher TC, Wittmann I.
PMID: 31121272
Diabetes Res Clin Pract. 2019 Jul;153:30-40. doi: 10.1016/j.diabres.2019.05.013. Epub 2019 May 20.

Dipeptidyl peptidase-4 (DPP-4) inhibitors are a class of glucose-lowering agent for type 2 diabetes (T2D) that are commonly used in clinical practice. With the recent disclosure of data from the CARMELINA cardiovascular outcomes trial (CVOT), which investigated linagliptin, CV...

Cite
Schernthaner G, Wanner C, Jurišić-Eržen D, et al. CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle. Diabetes Res Clin Pract. 2019;153:30-40doi: 10.1016/j.diabres.2019.05.013.
Schernthaner, G., Wanner, C., Jurišić-Eržen, D., Guja, C., Gumprecht, J., Jarek-Martynowa, I. R., Karasik, A., Lalić, N., Mankovsky, B. N., Prázný, M., Tankova, T., Tsur, A., Wascher, T. C., & Wittmann, I. (2019). CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle. Diabetes research and clinical practice, 15330-40. https://doi.org/10.1016/j.diabres.2019.05.013
Schernthaner, Guntram, et al. "CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle." Diabetes research and clinical practice vol. 153 (2019): 30-40. doi: https://doi.org/10.1016/j.diabres.2019.05.013
Schernthaner G, Wanner C, Jurišić-Eržen D, Guja C, Gumprecht J, Jarek-Martynowa IR, Karasik A, Lalić N, Mankovsky BN, Prázný M, Tankova T, Tsur A, Wascher TC, Wittmann I. CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle. Diabetes Res Clin Pract. 2019 Jul;153:30-40. doi: 10.1016/j.diabres.2019.05.013. Epub 2019 May 20. PMID: 31121272.
Copy Download .nbib Format: NLM
Critical Evaluation of the Methodologic Quality of the Top 50 Cited Articles Relating to Knee Dislocation and Multiligamentous Knee Injury.

Orthopaedic journal of sports medicine

Hankins DA, Fletcher IE, Prieto F, Ockuly AC, Myers OB, Treme GP, Veitch AJ, Wascher DC, Schenck RC, Richter DL.
PMID: 31742213
Orthop J Sports Med. 2019 Nov 08;7(11):2325967119880505. doi: 10.1177/2325967119880505. eCollection 2019 Nov.

BACKGROUND: Many studies have evaluated the management of knee dislocations (KDs) and multiligamentous knee injuries (MLKIs). However, no study to date has analyzed the quality of the most cited articles in this literature.HYPOTHESIS: There is a positive correlation between...

Cite
Hankins DA, Fletcher IE, Prieto F, et al. Critical Evaluation of the Methodologic Quality of the Top 50 Cited Articles Relating to Knee Dislocation and Multiligamentous Knee Injury. Orthop J Sports Med. 2019;7(11):2325967119880505doi: 10.1177/2325967119880505.
Hankins, D. A., Fletcher, I. E., Prieto, F., Ockuly, A. C., Myers, O. B., Treme, G. P., Veitch, A. J., Wascher, D. C., Schenck, R. C., & Richter, D. L. (2019). Critical Evaluation of the Methodologic Quality of the Top 50 Cited Articles Relating to Knee Dislocation and Multiligamentous Knee Injury. Orthopaedic journal of sports medicine, 7(11), 2325967119880505. https://doi.org/10.1177/2325967119880505
Hankins, David A, et al. "Critical Evaluation of the Methodologic Quality of the Top 50 Cited Articles Relating to Knee Dislocation and Multiligamentous Knee Injury." Orthopaedic journal of sports medicine vol. 7,11 (2019): 2325967119880505. doi: https://doi.org/10.1177/2325967119880505
Hankins DA, Fletcher IE, Prieto F, Ockuly AC, Myers OB, Treme GP, Veitch AJ, Wascher DC, Schenck RC, Richter DL. Critical Evaluation of the Methodologic Quality of the Top 50 Cited Articles Relating to Knee Dislocation and Multiligamentous Knee Injury. Orthop J Sports Med. 2019 Nov 08;7(11):2325967119880505. doi: 10.1177/2325967119880505. eCollection 2019 Nov. PMID: 31742213; PMCID: PMC6843738.
Copy Download .nbib Format: NLM
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy.

Journal of the National Cancer Institute

Prasanna PG, Citrin DE, Hildesheim J, Ahmed MM, Venkatachalam S, Riscuta G, Xi D, Zheng G, Deursen JV, Goronzy J, Kron SJ, Anscher MS, Sharpless NE, Campisi J, Brown SL, Niedernhofer LJ, O'Loghlen A, Georgakilas AG, Paris F, Gius D, Gewirtz DA, Schmitt CA, Abazeed ME, Kirkland JL, Richmond A, Romesser PB, Lowe SW, Gil J, Mendonca MS, Burma S, Zhou D, Coleman CN.
PMID: 33792717
J Natl Cancer Inst. 2021 Oct 01;113(10):1285-1298. doi: 10.1093/jnci/djab064.

Cellular senescence is an essential tumor suppressive mechanism that prevents the propagation of oncogenically activated, genetically unstable, and/or damaged cells. Induction of tumor cell senescence is also one of the underlying mechanisms by which cancer therapies exert antitumor activity....

Cite
Prasanna PG, Citrin DE, Hildesheim J, et al. Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy. J Natl Cancer Inst. 2021;113(10):1285-1298doi: 10.1093/jnci/djab064.
Prasanna, P. G., Citrin, D. E., Hildesheim, J., Ahmed, M. M., Venkatachalam, S., Riscuta, G., Xi, D., Zheng, G., Deursen, J. V., Goronzy, J., Kron, S. J., Anscher, M. S., Sharpless, N. E., Campisi, J., Brown, S. L., Niedernhofer, L. J., O'Loghlen, A., Georgakilas, A. G., Paris, F., Gius, D., Gewirtz, D. A., Schmitt, C. A., Abazeed, M. E., Kirkland, J. L., Richmond, A., Romesser, P. B., Lowe, S. W., Gil, J., Mendonca, M. S., Burma, S., Zhou, D., & Coleman, C. N. (2021). Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy. Journal of the National Cancer Institute, 113(10), 1285-1298. https://doi.org/10.1093/jnci/djab064
Prasanna, Pataje G, et al. "Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy." Journal of the National Cancer Institute vol. 113,10 (2021): 1285-1298. doi: https://doi.org/10.1093/jnci/djab064
Prasanna PG, Citrin DE, Hildesheim J, Ahmed MM, Venkatachalam S, Riscuta G, Xi D, Zheng G, Deursen JV, Goronzy J, Kron SJ, Anscher MS, Sharpless NE, Campisi J, Brown SL, Niedernhofer LJ, O'Loghlen A, Georgakilas AG, Paris F, Gius D, Gewirtz DA, Schmitt CA, Abazeed ME, Kirkland JL, Richmond A, Romesser PB, Lowe SW, Gil J, Mendonca MS, Burma S, Zhou D, Coleman CN. Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy. J Natl Cancer Inst. 2021 Oct 01;113(10):1285-1298. doi: 10.1093/jnci/djab064. PMID: 33792717; PMCID: PMC8486333.
Copy Download .nbib Format: NLM
Bucket handle meniscus tears in low-resource settings can be successfully treated with a cost-effective technique.

International orthopaedics

Imada AO, O'Hara JJ, Proumen IL, Molinari PS, Wascher DC, Richter DL, Schenck RC.
PMID: 34050384
Int Orthop. 2022 Jan;46(1):43-49. doi: 10.1007/s00264-021-05090-6. Epub 2021 May 29.

PURPOSE: In regions of the world where resources can limit medical care (limited-resource settings, LRS), most meniscal tears are often treated with meniscectomy. A simple, low-cost option for meniscal repair has been developed. We sought to evaluate patient reported...

Cite
Imada AO, O'Hara JJ, Proumen IL, et al. Bucket handle meniscus tears in low-resource settings can be successfully treated with a cost-effective technique. Int Orthop. 2021;46(1):43-49doi: 10.1007/s00264-021-05090-6.
Imada, A. O., O'Hara, J. J., Proumen, I. L., Molinari, P. S., Wascher, D. C., Richter, D. L., & Schenck, R. C. (2022). Bucket handle meniscus tears in low-resource settings can be successfully treated with a cost-effective technique. International orthopaedics, 46(1), 43-49. https://doi.org/10.1007/s00264-021-05090-6
Imada, Allicia Ostoposides, et al. "Bucket handle meniscus tears in low-resource settings can be successfully treated with a cost-effective technique." International orthopaedics vol. 46,1 (2022): 43-49. doi: https://doi.org/10.1007/s00264-021-05090-6
Imada AO, O'Hara JJ, Proumen IL, Molinari PS, Wascher DC, Richter DL, Schenck RC. Bucket handle meniscus tears in low-resource settings can be successfully treated with a cost-effective technique. Int Orthop. 2022 Jan;46(1):43-49. doi: 10.1007/s00264-021-05090-6. Epub 2021 May 29. PMID: 34050384.
Copy Download .nbib Format: NLM
Showing 37 to 45 of 45 entries